I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Deep, rapid, and durable prostate-specific antigen decline ..:
Chowdhury S
;
Bjartell A
;
Agarwal N
...
Annals of Oncology. , 2023
Link:
https://doi.org/10.1016/j.annonc.2023.02.009
RT Journal T1
Deep, rapid, and durable prostate-specific antigen decline with apalutamide plus androgen deprivation therapy is associated with longer survival and improved clinical outcomes in TITAN patients with metastatic castration-sensitive prostate cancer
UL https://suche.suub.uni-bremen.de/peid=base-ftistanbulcuniv:oai:acikerisim.iuc.edu.tr:20.500.12831_12677&Exemplar=1&LAN=DE A1 Chowdhury S A1 Bjartell A A1 Agarwal N A1 Chung B.H A1 Given R.W A1 Pereira de Santana Gomes A.J A1 Merseburger A.S A1 Chi, K.N A1 Özgüroglu, M PB Elsevier Ltd YR 2023 K1 castration resistance K1 mCSPC K1 overall survival K1 PSA progression K1 radiographic progression-free survival K1 androgen K1 antiandrogen K1 apalutamide K1 prostate specific antigen K1 castration K1 castration resistant prostate cancer K1 controlled study K1 human K1 male K1 randomized controlled trial K1 Androgen Antagonists K1 Androgens K1 Humans K1 Prostate-Specific Antigen K1 Prostatic Neoplasms K1 Castration-Resistant JF Annals of Oncology LK http://dx.doi.org/https://doi.org/10.1016/j.annonc.2023.02.009 DO https://doi.org/10.1016/j.annonc.2023.02.009 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)